RQ Bio
Develops antibody therapies to prevent seasonal influenza in high-risk and immunocompromised patients
$115MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Pitching LifeArc? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room